{"id":"W4226062860","doi":"10.1177/17562864211058298","title":"Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"EMD Serono; MedDay Pharmaceuticals; Genentech; Serono Symposia International Foundation; Servier; Aristotle University of Thessaloniki; Pirogov Russian National Research Medical University; Medizinische Universität Wien; Rigshospitalet; Università degli Studi di Genova; Hebrew University of Jerusalem; Universität Wien; Queen Mary University of London; CSL Behring; Gentofte Hospital; Fresenius Medical Care North America; Five Prime Therapeutics; Ironwood Pharmaceuticals, Incorporated; Vertex Pharmaceuticals; Ottawa Hospital Research Institute; Bayer Vital; Bristol-Myers Squibb; Bundesministerium für Bildung und Forschung; Atara Biotherapeutics; Merck KGaA; Univerzita Karlova v Praze; Pfizer; Biogen; Celgene; Teva Pharmaceutical Industries; Sanofi; GW Pharmaceuticals; Università degli Studi di Napoli Federico II; Bayer HealthCare; Deutsche Forschungsgemeinschaft; Directorate for Biological Sciences; GlaxoSmithKline","keywords":"Cladribine; Medicine; Expert opinion; Vaccination; Coronavirus disease 2019 (COVID-19); Clinical Practice; Dosing; MEDLINE; Multiple sclerosis; Family medicine; Intensive care medicine; Pharmacology; Internal medicine; Pathology; Immunology; Disease; Infectious disease (medical specialty)","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1315792,0.001059415,0.002314884,0.004180183,0.001698493,0.004742271,0.005417064,0.01505625,0.006046822],"category_scores_gemma":[0.3006422,0.001009022,0.003473654,0.003339917,0.002806859,0.004158759,0.005152978,0.009009349,0.003216819],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005387257,"about_ca_system_score_gemma":0.02824574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003553326,"about_ca_topic_score_gemma":0.003491802,"domain_scores_codex":[0.8250086,0.09556503,0.04417398,0.005548409,0.02602924,0.003674609],"domain_scores_gemma":[0.5991156,0.1746227,0.03400208,0.006424023,0.1722912,0.01354438],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004695799,0.0001524929,0.004641457,0.033174,0.000893531,0.001327451,0.006360913,0.001434758,0.001826011,0.006751625,0.5708927,0.3720755],"study_design_scores_gemma":[0.0003740803,0.0002744531,0.003517507,0.08575629,0.0009597664,0.001310395,0.004652513,0.001498608,0.0009807644,0.01512664,0.8853227,0.0002264112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.00722045,0.123658,0.01617299,0.772674,0.04206736,0.002073233,0.001208445,0.000183915,0.03474165],"genre_scores_gemma":[0.2168785,0.2517527,0.1338226,0.3353083,0.0375441,0.005425471,0.003594156,0.0002525749,0.01542147],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.1315792,"threshold_uncertainty_score":0.6958658,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3187153313532363,"score_gpt":0.5275843612080184,"score_spread":0.2088690298547822,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}